Arguments in the challenge to the abortion drug mifepristone suggest the US Supreme Court will nix the dispute on technical standing grounds.
Justices from across the ideological spectrum suggested on March 26 the anti-abortion doctors at the center of the case were asking too much.
“Cases and Controversies” hosts run through the lopsided arguments that focused little on the merits and almost exclusively on whether the doctors could prevent access to the drug nationwide.
Listen and subscribe to Cases and Controversies on Apple Podcasts , Spotify, Google Podcasts Megaphone, or Audible.
They also discuss how the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.